학술논문
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
Document Type
Article
Author
Source
In: Diagnostic Microbiology and Infectious Disease . (Diagnostic Microbiology and Infectious Disease, November 2022, 104(3))
Subject
Language
English
ISSN
18790070
07328893
07328893